Proteocyte AI

01/20/2026

Meet our Principal US Lab Director, Dr. Paras Patel, DDS. Dr. Patel is a board certified oral and maxillofacial pathologist, who obtained his dental degree from Howard University College of Dentistry and went on to complete his residency in Oral and Maxillofacial Pathology from (Baylor) College of Dentistry.

Upon completion of his residency, Dr. Patel took a position at the college of dentistry as a full-time faculty member. After 5 years in academia, he transitioned to private practice and established the Center for Oral Pathology, where he clinically manages patients with a wide variety of oral diseases.

He also had the opportunity to continue his practice of surgical pathology in conjunction with ProPath, where he was instrumental in establishing the division of oral and maxillofacial pathology, where he currently serves as director. Dr. Patel also stays active in clinical research involving oral potentially malignant disorders/precancerous lesions and oral cancer.

"I grew up in a humanitarian-driven healthcare environment and believe that patients come first. In a field where there have been no advances in diagnostics as well as treatment and management, I feel it is my obligation to make a difference. I have personally and professionally seen what this disease does to the individuals afflicted, and am adamant that we as a community do something to change the future."

Learn more: https://proteocyte.com/team/


Dental Association des chirurgiens dentistes du Québec - ACDQ Cancer Foundation Dental Association Care Manitoba Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Partnership Against Cancer Research Society québécoise du cancer Dental Association Brunswick Dental Society and Labrador Dental Association Scotia Dental Association Dental Association (ODA) Society of Oral & Maxillofacial Surgeons Fox Foundation Princess Margaret Cancer Foundation Academy of Otolaryngology ACADEMY OF ORAL MEDICINE Academy of Oral and Maxillofacial Pathology Association of Oral and Maxillofacial Surgeons American Cancer Society American Dental Association Oral & Maxillofacial Surgeons Oral Surgery & Neck Cancer Alliance Science Foundation Oral Cancer Foundation
Oral Health Jaw Surgery of OMS Administrators
SPOHNC Mouth Cancer Foundation Foundation Oral Health Foundation events

01/15/2026

Did you know the global 5-year survival rate for oral cancer is only ~50%?

And nearly 70% of cases aren’t diagnosed until Stage 3 or 4—when treatment becomes far more complex and outcomes decline.

In North America alone, oral cancer takes one life every hour.

Oral cancer often begins as a precancerous lesion, which can appear anywhere in the mouth—on the lips, cheeks, tongue, gums, or palate. These lesions may show up as red, white, or mixed-colour patches. They often don’t hurt, don’t heal, and may go unnoticed until spotted during a routine dental exam.

To determine whether a lesion is a precancer (an OPMD), a biopsy is needed. This tissue sample is reviewed by a pathologist under the microscope through a process called histopathology.

That’s where STRATICYTE® can make a critical difference.

Using AI-driven biomarker analysis and digital pathology, STRATICYTE® supplements traditional histopathology by providing an objective, personalized 5-year oral cancer risk score.

Your STRATICYTE® report will clearly classify your lesion as low risk or elevated risk, giving your healthcare professional the clarity needed to make more confident, evidence-based decisions about your care.

Early detection saves lives. And having accurate risk information helps ensure timely intervention for high-risk patients while reducing unnecessary treatment for those at lower risk.

Ask your healthcare provider about STRATICYTE®.

Learn more: https://proteocyte.com/straticyte/patients/


Dental Association des chirurgiens dentistes du Québec - ACDQ Cancer Foundation Dental Association Care Manitoba Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Partnership Against Cancer Research Society québécoise du cancer Dental Association Brunswick Dental Society and Labrador Dental Association Scotia Dental Association Dental Association (ODA) Society of Oral & Maxillofacial Surgeons The Terry Fox Foundation The Princess Margaret Cancer Foundation Academy of Otolaryngology ACADEMY OF ORAL MEDICINE Academy of Oral and Maxillofacial Pathology Association of Oral and Maxillofacial Surgeons American Cancer Society American Dental Association Oral & Maxillofacial Surgeons Oral Surgery & Neck Cancer Alliance Science Foundation Oral Cancer Foundation
Oral Health Jaw Surgery of OMS Administrators
SPOHNC Mouth Cancer Foundation Foundation Oral Health Foundation events

01/13/2026

We want to hear from you.

In this update, Dr. Paras Patel invites clinicians to share their STRATICYTE® experience—how the test is supporting more objective evaluation, clearer guidance, and better education for patients with OPMDs.

From provider feedback to patient stories, STRATICYTE® is helping bring clarity to what each patient should do next in managing their lesion.

Have insights to share? Join the conversation.


Dental Association des chirurgiens dentistes du Québec - ACDQ Cancer Foundation Dental Association Care Manitoba Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Partnership Against Cancer Research Society québécoise du cancer Dental Association Brunswick Dental Society and Labrador Dental Association Scotia Dental Association Dental Association (ODA) Society of Oral & Maxillofacial Surgeons The Terry Fox Foundation The Princess Margaret Cancer Foundation Academy of Otolaryngology ACADEMY OF ORAL MEDICINE Academy of Oral and Maxillofacial Pathology Association of Oral and Maxillofacial Surgeons American Cancer Society American Dental Association Oral & Maxillofacial Surgeons Oral Surgery Head and Neck Cancer Alliance Science Foundation Oral Cancer Foundation
Oral Health Jaw Surgery of OMS Administrators
SPOHNC Mouth Cancer Foundation Foundation Oral Health Foundation events

01/06/2026

We are thrilled to kick off 2026 by extending the PAISIP (Proteocyte AI Shared Innovation Program) offer to Jan 31, 2026!

2025 was a landmark year for Proteocyte AI, marked by widespread North American adoption of the STRATICYTE® test and a pivotal advance in oral cancer risk prediction. Now is the time to build on this momentum to deliver even better patient outcomes and create lasting change in how oral cancer risk is detected and managed and we invite you to join us on this journey.

✅ Get early OSCC prediction
✅ Give patients a 5-year window to OSCC risk

Our Offer: Increase OSCC detection + prediction. Proactively manage oral precancer patients

Our Ask: Order the test and share feedback on the process, the report, and its utility

For precision and peace of mind, go beyond standard in 2026 and order the STRATICYTE ® test. Together, we can improve oral precancer patient care and outcomes .

Contact us to learn more: clientservices@proteocyte.com
https://proteocyte.com/about/contact/

Order STRATICYTE® : https://proteocyte.com/ordering-options/


Dental Association des chirurgiens dentistes du Québec - ACDQ Cancer Foundation Dental Association Care Manitoba Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Partnership Against Cancer Research Society québécoise du cancer Dental Association Brunswick Dental Society and Labrador Dental Association Scotia Dental Association Dental Association (ODA) Society of Oral & Maxillofacial Surgeons Terry Fox Foundation Princess Margaret Cancer Foundation Academy of Otolaryngology ACADEMY OF ORAL MEDICINE Academy of Oral and Maxillofacial Pathology Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Oral & Maxillofacial Surgeons Oral Surgery & Neck Cancer Alliance Science Foundation Cancer Foundation
Oral Health Jaw Surgery of OMS Administrators
SPOHNC Mouth Cancer Foundation Foundation Health Foundation events

12/19/2025

📄 What’s included in a STRATICYTE® report?

STRATICYTE® is supported by over a decade of clinical research and robust clinical validation which continues to be strengthened by ongoing studies with major oral pathology centres in North America.

Each STRATICYTE® report provides:

✔️ A personalized 5-year cancer risk score
✔️ Clear classification of low vs. elevated risk

This comprehensive insight helps clinicians confidently manage oral precancer patients with evidence-based precision.

👉 Watch this short video to learn about this novel test: https://www.youtube.com/watch?v=m7boEYIsQpk

Dental Association des chirurgiens dentistes du Québec - ACDQ Cancer Foundation Dental Association Manitoba Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Partnership Against Cancer de recherche sur le cancer / Cancer Research Society québécoise du cancer Dental Association Dental Society and Labrador Dental Association Scotia Dental Association Dental Association Society of Oral and Maxillofacial Surgery The Terry Fox Foundation The Princess Margaret Cancer Foundation Academy of Otolaryngology—Head and Neck Surgery Academy of Oral Medicine Academy of Oral and Maxillofacial Pathology - AAOMP Association of Oral and Maxillofacial Surgeons - AAOMS American Cancer Society American Dental Association Oral & Maxillofacial Surgeons Oral Surgery Head and Neck Cancer Alliance Science Foundation Oral Cancer Foundation Oral Health Jaw Surgery of OMS Administrators SPOHNC Mouth Cancer Foundation Foundation Oral Health Foundation Events

12/16/2025

Heather discovered an oral lesion. In this video, Heather reveals what happened next and how STRATICYTE® helped shape her course of treatment and future care decisions.

As a patient/family member of a patient STRATICYTE® brings
✅ Peace of Mind: Timely, accurate results
✅ Clarity: Early diagnosis for optimal treatment and outcomes
✅ A Path Forward: Patient empowerment, Informed decision-making

Learn more: https://proteocyte.com/straticyte/patients/

Dental Association des chirurgiens dentistes du Québec - ACDQ Cancer Foundation Dental Association Manitoba Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Partnership Against Cancer de recherche sur le cancer / Cancer Research Society québécoise du cancer Dental Association Dental Society and Labrador Dental Association Scotia Dental Association Dental Association Society of Oral and Maxillofacial Surgery The Terry Fox Foundation Princess Margaret Cancer Foundation Academy of Otolaryngology—Head and Neck Surgery Academy of Oral Medicine Academy of Oral and Maxillofacial Pathology - AAOMP Association of Oral and Maxillofacial Surgeons - AAOMS American Cancer Society American Dental Association Oral & Maxillofacial Surgeons Oral Surgery Head and Neck Cancer Alliance Science Foundation Oral Cancer Foundation Oral Health Jaw Surgery of OMS Administrators SPOHNC Mouth Cancer Foundation Foundation Oral Health Foundation Events

12/12/2025

For a limited time, get expanded access to our exclusive test, STRATICYTE® through the 2025

PAISIP (Proteocyte AI Shared Innovation Program)
Order STRATICYTE® at https://proteocyte.com/ordering-options/

Get early OSCC prediction
Give patients a 5-year window to OSCC risk

Our Offer: Increase OSCC detection + prediction. Proactively manage OPMD patients
Our Ask: Order the test and share feedback on the process, the report, and its utility

Together, we can improve OPMD patient care and outcomes

Order STRATICYTE® at https://proteocyte.com/ordering-options/

LEARN MORE: watch our intro on “What is STRATICYTE and how can it help?”
https://www.youtube.com/watch?v=m7boEYIsQpk

Email clientservices@proteocyte.com for more info

Dental Association des chirurgiens dentistes du Québec - ACDQ Cancer Foundation Dental Association Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Partnership Against Cancer de recherche sur le cancer / Cancer Research Society québécoise du cancer Dental Association Dental Society and Labrador Dental Association Scotia Dental Association Dental Association Society of Oral and Maxillofacial Surgery The Terry Fox Foundation Princess Margaret Cancer Foundation Academy of Otolaryngology—Head and Neck Surgery Academy of Oral Medicine Academy of Oral and Maxillofacial Pathology - AAOMP Cancer Society Dental Association Oral & Maxillofacial Surgeons Oral Surgery and Neck Cancer Alliance Science Foundation Cancer Foundation Oral Health Jaw Surgery of OMS Administrators SPOHNC Mouth Cancer Foundation Foundation Oral Health Foundation

12/11/2025

STRATICYTE® is the only objective test that can distinguish oral lesions at elevated risk of becoming cancerous from those with little to no risk. Built on over a decade of clinical research and robust clinical validation, STRATICYTE® empowers clinicians to personalize patient management and support better outcomes.

🧬 How do I order STRATICYTE®?

Ordering STRATICYTE®easily integrates into your existing workflow.

Simply:
1️⃣ Go to our website
2️⃣ Download the Test Request Form
3️⃣ Proteocyte AI does the rest!

👉 Learn more about the ordering process at https://proteocyte.com/ordering-options/

Dental Association des chirurgiens dentistes du Québec - ACDQ Cancer Foundation Dental Association Manitoba Association of Oral and Maxillofacial Surgeons Cancer Society Dental Association Partnership Against Cancer de recherche sur le cancer / Cancer Research Society québécoise du cancer Dental Association Dental Society and Labrador Dental Association Scotia Dental Association Dental Association Society of Oral and Maxillofacial Surgery The Terry Fox Foundation Princess Margaret Cancer Foundation Academy of Otolaryngology—Head and Neck Surgery Academy of Oral Medicine Academy of Oral and Maxillofacial Pathology - AAOMP Association of Oral and Maxillofacial Surgeons - AAOMS Cancer Society Dental Association Oral & Maxillofacial Surgeons Oral Surgery and Neck Cancer Alliance Science Foundation Oral Cancer Foundation Oral Health Jaw Surgery of OMS Administrators SPOHNC Mouth Cancer Foundation Foundation Oral Health Foundation Events

12/04/2025

Proteocyte AI is on a mission to increase early oral cancer detection and prediction, and decrease oral cancer fatalities, through expanded access to our exclusive test:

For a limited time, Proteocyte AI is offering expanded access to their exclusive OSCC prognostic, STRATICYTE® test through the PAISIP (Proteocyte AI Shared Innovation Program).

Built on extensive precancer research, Proteocyte AI knows diagnosing oral potentially malignant disease (OPMD) is complex, and lack of precise risk stratification can lead to disease progression and higher costs. Proteocyte AI is on a mission to change that – enabling earlier, proactive management of oral precancer patients.

Proteocyte AI’s PAISIP fosters vital scientific collaboration & clinical experience through STRATICYTE® – your 5-year window to oral cancer risk.

Our Offer: increase early OSCC detection and prediction to enable earlier, more proactive management of oral precancer patients

Our Ask: order STRATICYTE ®, share feedback with our Client Services team regarding the process, resulting report, and clinical utility

Our Role: Client Services provides end-to-end support for a seamless process

To order STRATICYTE®, visit: https://proteocyte.com/ordering-options/

Together, we can improve OPMD patient care and outcomes.

Learn how Proteocyte AI’s PAISIP works for you to help patients live better, longer: https://proteocyte.com/about/contact/

Watch "What is STRATICYTE and how can it help?": https://youtu.be/m7boEYIsQpk?si=T2Xu4NmRtVlRjdIY

, des chirurgiens dentistes du Québec - ACDQ , Cancer Foundation , Dental Association , Care Manitoba , Association of Oral and Maxillofacial Surgeons , Cancer Society , Dental Association , Partnership Against Cancer , Research Society , québécoise du cancer , Dental Association , Brunswick Dental Society , and Labrador Dental Association , Scotia Dental Association , Dental Association (ODA) , Society of Oral & Maxillofacial Surgeons , Fox Foundation , Princess Margaret Cancer Foundation , Academy of Otolaryngology , ACADEMY OF ORAL MEDICINE , Academy of Oral and Maxillofacial Pathology , Association of Oral and Maxillofacial Surgeons , Cancer Society , Dental Association , Oral & Maxillofacial Surgeons , Oral Surgery , & Neck Cancer Alliance , Science Foundation , Cancer Foundation , Oral Health , Jaw Surgery , of OMS Administrators , For People With Oral And Head And Neck Cancer (SPOHNC) Cancer Foundation , Foundation , Health Foundation , events

A test that assesses the risk of trasformation of an oral pre-malignant lesion to invasive oral cancer.

11/26/2025

What are the cost considerations and reimbursement pathways associated with adopting Straticyte?

Adopting innovative diagnostics often raises questions about financial feasibility. Here’s what clinicians need to know:
✔️ STRATICYTE™ can help reduce long-term healthcare costs by preventing late-stage oral cancer
✔️ By enabling earlier intervention, it lowers the need for more intensive, costly treatments
✔️ Reimbursement pathways are emerging as predictive diagnostics gain recognition in clinical practice

In short: investing in STRATICYTE™ not only supports better patient outcomes but also contributes to more sustainable healthcare.

➡️ Watch the video: https://proteocyte.com/video-gallery/

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , American Academy of Oral Medicine , American Academy of Oral and Maxillofacial Pathology - AAOMP , Canadian Dental Association , Canadian Association of Oral and Maxillofacial Surgeons , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association , SurgeOn Events

11/20/2025

Thank you to everyone who joined the AAOM Educational Webinar: AI and Biomarker-Guided Diagnostics in Oral Lesions: From Risk Stratification to Clinical Pathways.

An excellent CE event with valuable insights shared by 2 experts in their respective fields; Dr. Paras Patel, Oral and Maxillofacial PathologistDirector of the Oral Maxillofacial Pathology Department at Propath, Dallas, TX and Dr. Waleed Zaid, Professor, Fellowship Director, Head and Neck Oncology and Microvascular Surgery, LSU Health New Orleans

Couldn’t make it live? You can view the recording and learn more about Proteocyte AI and the role of prognostic tools in oral cancer risk assessment here: https://vimeo.com/1134602267?share=copy

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , American Academy of Oral Medicine , American Academy of Oral and Maxillofacial Pathology - AAOMP , Canadian Dental Association , Canadian Association of Oral and Maxillofacial Surgeons , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association , SurgeOn Events

11/18/2025

Get to know the Proteocyte team!

Meet our Principal Scientist & Lab Manager, Jason Hwang. Jason is fluent in the field of cell differentiation/signaling and cancer metastasis, with over 10 years of research lab experience. He has overseen multiple research projects including the supervision of graduate/undergraduate students and other lab members, and is the co-inventor of Proteocyte’s first patent for the automated method for assessing oral cancer risk progression. He obtained his HBSc in Cell biology, and his MSc and PhD in Cell & Developmental Biology from The University of Western Ontario in London, Ontario.

“Advances in protein biomarker-based computational analysis are driving the adoption of digital pathology and machine learning–based diagnostics across modern healthcare. Proteocyte’s flagship product, Straticyte, utilizes high-resolution whole-slide imaging and advanced AI analysis to deliver individualized, quantitative, and reproducible assessments of oral cancer transformation risk—enhancing and complementing traditional histopathology. Having been part of Proteocyte's journey over the past decade and finally seeing this innovation take flight has been an incredibly rewarding experience."

Ontario Dental Association , American Association of Oral and Maxillofacial Surgeons - AAOMS , American Academy of Oral Medicine , American Academy of Oral and Maxillofacial Pathology - AAOMP , Canadian Dental Association , Canadian Association of Oral and Maxillofacial Surgeons , ™, American Academy of Otolaryngology—Head and Neck Surgery , American Dental Association , SurgeOn Events